Скачать или смотреть Metabesity 2020: Policy, Payers, and Providers

A Metabesity conference session on how closely related to regulation of healthspan products and clinical evidence needed for their approval are questions that healthcare payers and providers have about Metabesity approaches. A traditional insurer may be ambivalent about paying for preventative therapies that may not ‘pay off’ in the form of delayed or avoided chronic illnesses decades later. A traditional insurer, a managed care provider, emerging healthcare providers with novel models, and a single payer government system prioritize increasing healthspan differently. Two experts who deftly illuminated this labyrinth at Metabesity 2019 update their discussion.

Ed Saltzman, Executive Chairman at Cello Health BioConsulting
Ryan Walsh, Vice President for Client Services at Real Endpoints